West Pharmaceutical Services, Inc. WST
370.44
(3.16)
(0.85%)
as of 25 Sep
- Market cap
- $26.3B
- P/E
- 47.1×
Follow WST
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
West Pharmaceutical Services, Inc. (WST) Total debt
West Pharmaceutical Services, Inc.'s total debt at the end of fiscal 2025 was $202.8M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $202.9M. Over the past ten years it has ranged from $72.8M (fiscal 2023) to $255.0M (fiscal 2019); the current reading is higher than 45% of that period. West Pharmaceutical Services, Inc. ranks 19th of 55 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $202.8M | 0.10% |
| FY2024 | $202.6M | 178.30% |
| FY2023 | $72.8M | (64.78%) |
| FY2022 | $206.7M | (1.01%) |
| FY2021 | $208.8M | (17.44%) |
| FY2020 | $252.9M | (0.82%) |
| FY2019 | $255.0M | 30.10% |
| FY2018 | $196.0M | (0.51%) |
| FY2017 | $197.0M | (12.91%) |
| FY2016 | $226.2M | (1.18%) |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $202.9M | 0.05% |
| Mar 2026 | $202.8M | 0.00% |
| Dec 2025 | $202.8M | 0.05% |
| Sep 2025 | $202.7M | 0.05% |
| 42 more quarters | Free account |
Against its own ten years
Low $72.8M
High $255.0M
Ten-year median
$206.7M
Current reading's percentile
45
Total debt against peers
| Company | Total debt |
|---|---|
| BDX Becton, Dickinson and Company compare | $13.5B |
| MDLN Medline Inc. compare | $12.6B |
| BAX Baxter International Inc. compare | $9.5B |
| SOLV Solventum Corporation compare | $5.3B |
| ALC Alcon compare | $4.7B |
| COO The Cooper Companies, Inc. compare | $2.5B |
| RGEN Repligen Corporation compare | $551.0M |
| RMD ResMed Inc. compare | $399.4M |
| WST West Pharmaceutical Services, Inc. | $202.9M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on WST
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement